901 followers
Montelukast (Asthmamittel) Charakteristika: Antiasthmatikum, Leukotrien-Rezeptor-Antagonist https://t.co/CfPVrly3RD
Montelukast (Asthmamittel) Charakteristika: Antiasthmatikum, Leukotrien-Rezeptor-Antagonist https://t.co/CfPVrly3RD
@Christina_Wood1 @njp000 @breakfastnick Another study: https://t.co/yt82J7wUCK
@ahandvanish There is also this trial of @mera_cordero https://t.co/s8UV3K5pnH about montelukast
RT @2dedostesta2: “The study will be carried out from August 1, 2021, to March 1, 2023.” https://t.co/0KpGGl9I1v